HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Related articles in The JI Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Beek, J. Articles by Gasque, P. Search for Related Content PubMed PubMed Citation Articles by van Beek, J. Articles by Gasque, P.

Decay-Accelerating Factor (CD55) Is Expressed by Neurons in Response to Chronic but Not Acute Autoimmune Central Nervous System Inflammation Associated with Complement Activation¹

Johan van Beek^2,*, Marjan van Meurs^,¶, Bert A. ‘t Hart^¶,||, Herbert P. M. Brok^||, Jim W. Neal^*,, Alexandra Chatagner^*, Claire L. Harris, Nader Omidvar, B. Paul Morgan, Jon D. Laman^,¶ and Philippe Gasque^2,*

^* Brain Inflammation Immunity Group (BIIG) and Complement Biology Group (CBG), Department of Medical Biochemistry and Immunology and Department of Pathology, Cardiff University, Cardiff, United Kingdom; Department of Immunology, Erasmus Medical Center, and ^¶ Centre ErasMS, Rotterdam, The Netherlands; and ^|| Department of Immunobiology, Biomedical Primate Research Centre, Rijswijk, The Netherlands

There is compelling evidence that a unique innate immune response in the CNS plays a critical role in host defense and clearance of toxic cell debris. Although complement has been implicated in neuronal impairment, axonal loss, and demyelination, some preliminary evidence suggests that the initial insult consequently activates surrounding cells to signal neuroprotective activities. Using two different models of experimental autoimmune encephalomyelitis, we herein demonstrate selective C1q complement activation on neuron cell bodies and axons. Interestingly, in brains with chronic but not acute experimental autoimmune encephalomyelitis, C3b opsonization of neuronal cell bodies and axons was consistently associated with robust neuronal expression of one of the most effective complement regulators, decay-accelerating factor (CD55). In contrast, levels of other complement inhibitors, complement receptor 1 (CD35), membrane cofactor protein (CD46), and CD59 were largely unaffected on neurons and reactive glial cells in both conditions. In vitro, we found that proinflammatory stimuli (cytokines and sublytic doses of complement) failed to up-regulate CD55 expression on cultured IMR32 neuronal cells. Interestingly, overexpression of GPI-anchored CD55 on IMR32 was capable of modulating raft-associated protein kinase activities without affecting MAPK activities and neuronal apoptosis. Critically, ectopic expression of decay-accelerating factor conferred strong protection of neurons against complement attack (opsonization and lysis). We conclude that increased CD55 expression by neurons may represent a key protective signaling mechanism mobilized by brain cells to withstand complement activation and to survive within an inflammatory site.

Related articles in The JI:

IN THIS ISSUE

The JI 2005 174: 1773-1774. [Full Text]  

This article has been cited by other articles:

				M. R. Griffiths, J. W. Neal, M. Fontaine, T. Das, and P. Gasque Complement Factor H, a Marker of Self Protects against Experimental Autoimmune Encephalomyelitis J. Immunol., April 1, 2009; 182(7): 4368 - 4377. [Abstract] [Full Text] [PDF]

				R. M. Donev, L. C. Gray, B. Sivasankar, T. R. Hughes, C. W. van den Berg, and B. P. Morgan Modulation of CD59 Expression by Restrictive Silencer Factor-Derived Peptides in Cancer Immunotherapy for Neuroblastoma Cancer Res., July 15, 2008; 68(14): 5979 - 5987. [Abstract] [Full Text] [PDF]

				E. K. Mathey, T. Derfuss, M. K. Storch, K. R. Williams, K. Hales, D. R. Woolley, A. Al-Hayani, S. N. Davies, M. N. Rasband, T. Olsson, et al. Neurofascin as a novel target for autoantibody-mediated axonal injury J. Exp. Med., October 1, 2007; 204(10): 2363 - 2372. [Abstract] [Full Text] [PDF]

				M. I. Leite, M. Jones, P. Strobel, A. Marx, R. Gold, E. Niks, J. J.G.M. Verschuuren, S. Berrih-Aknin, F. Scaravilli, A. Canelhas, et al. Myasthenia Gravis Thymus: Complement Vulnerability of Epithelial and Myoid Cells, Complement Attack on Them, and Correlations with Autoantibody Status Am. J. Pathol., September 1, 2007; 171(3): 893 - 905. [Abstract] [Full Text] [PDF]

				I Garcia-Valladares, Y Atisha-Fregoso, Y Richaud-Patin, J Jakez-Ocampo, E Soto-Vega, D Elias-Lopez, E Carrillo-Maravilla, J Cabiedes, A Ruiz-Arguelles, and L Llorente Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia Lupus, September 1, 2006; 15(9): 600 - 605. [Abstract] [PDF]

				Z. Wang, V. M. Aris, K. D. Ogburn, P. Soteropoulos, and M. E. Figueiredo-Pereira Prostaglandin J2 Alters Pro-survival and Pro-death Gene Expression Patterns and 26 S Proteasome Assembly in Human Neuroblastoma Cells J. Biol. Chem., July 28, 2006; 281(30): 21377 - 21386. [Abstract] [Full Text] [PDF]

				N. Omidvar, E. C. Y. Wang, P. Brennan, M. P. Longhi, R. A. G. Smith, and B. P. Morgan Expression of Glycosylphosphatidylinositol-Anchored CD59 on Target Cells Enhances Human NK Cell-Mediated Cytotoxicity. J. Immunol., March 1, 2006; 176(5): 2915 - 2923. [Abstract] [Full Text] [PDF]

				R. M. Donev, D. S. Cole, B. Sivasankar, T. R. Hughes, and B. P. Morgan p53 Regulates Cellular Resistance to Complement Lysis through Enhanced Expression of CD59 Cancer Res., February 15, 2006; 66(4): 2451 - 2458. [Abstract] [Full Text] [PDF]